کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
9616789 48929 2005 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Endorsing functionality of Burkholderia pseudomallei glyoxylate cycle genes as anti-persistence drug screens
موضوعات مرتبط
مهندسی و علوم پایه مهندسی شیمی کاتالیزور
پیش نمایش صفحه اول مقاله
Endorsing functionality of Burkholderia pseudomallei glyoxylate cycle genes as anti-persistence drug screens
چکیده انگلیسی
Isocitrate lyase (ICL) and malate synthase (MS) are key glyoxylate cycle enzymes shown to be required for the persistence and virulence of Candida albicans and of Mycobacterium tuberculosis in macrophages because the up-regulation of glyoxylate genes and the corresponding enzymes could replenish C4 carbohydrates from C2 compounds in a persistent pathogen. In this study, the ace (acetate) genes (aceA and aceB) of a persistent pathogen, Burkholderia pseudomallei (ATCC 23343), encoding an ICL and a MS, respectively, were isolated and fully sequenced. The genes, aceA (1.3 kb) and aceB (1.6 kb) were cloned and expressed as tagged fusion proteins in Escherichia coli BL21 (DE3). The molecular weights of the predicted enzymes (ICL, 47.7 kDa and MS, 59.1 kDa) were consistent with ICLs and MSs reported so far. Phylogenetic analysis of these genes revealed significant identity (80-90%) with most bacterial ICLs and MSs. Comparative structural modeling and the localization of major ICL and MS family domains in the deduced peptide sequences showed interestingly significant similarity with isozymes from known pathogens. Specific activities of expressed ICL (589.27 nmol min−1 mg−1) and MS (485.54 nmol min−1 mg−1) were also demonstrated. Taken together, these results provide evidence for the functionality of glyoxylate cycle genes in B. pseudomallei and may thus be useful for designing antimicrobials targeted at the glyoxylate cycle.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Molecular Catalysis B: Enzymatic - Volume 33, Issues 1–2, 3 May 2005, Pages 51-56
نویسندگان
, , ,